An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 7th December, 2012
Time: Networking 4:00pm, Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: On The Edge
Presented by Dave Darling, CEO of Pacific Edge

On the edge of a new year, the 2012 MBioEnt students on the edge of their professional career and Pacific Edge on the edge of……..global domination?

We are delighted that Dave Darling, CEO of Pacific Edge, will be the guest speaker for the final Bioscience Enterprise forum for 2012.

Specialising in using proteomic and genomic tools to develop technologies that allow earlier detection and monitoring of cancer, Pacific Edge not only identifies reliable biomarkers but also develops novel simple-to-use tests that have high accuracy and utility and so provide significant advances in clinical practice. They also provide the analysis for these tests through a laboratory service.

With Cxbladder on the market, Cxcolorectal in the final stages of development, a test for gastric cancer and another for melanoma in pre-clinical trials, Pacific Edge is already impacting on the field of cancer diagnosis and prognosis. They currently provide a laboratory service in New Zealand and Australia and are set to expand. Pacific Edge now has a wholly-owned subsidiary in the US – a purpose-built laboratory in Hershey, Pennsylvania with the capacity to carry out 260,000 tests for bladder cancer per year. This facility, due to be granted regulatory approval by early 2013, is intended to provide a better and more cost-effective choice to the 17,000 urologists in the US who currently spend $1 billion annually identifying bladder cancer in their patients. The fact that this facility was finished both on-schedule and within budget is certainly a positive start!

Dave joined Pacific Edge in 2003 bringing a wealth of experience in developing start-ups and early stage technologies. He has led Pacific Edge from its discovery stage through to commercialisation. While the US lab ‘going–live’ commercially in 2013 will no doubt be a wonderful 10th birthday present there have been many challenges along the way. This presentation will provide insight to some of those (sometimes unexpected) challenges.

Please join us to celebrate the end of the year and to hear CEO Dave Darling talk about Pacific Edge’s road to success.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 373 7599 ext 89625 or 0274 305 758.